Roche Buys Cancer Drug Maker Ignyta In A $1.7 Billion Deal

Roche Holding (RHHBY) agreed to acquire U.S. biotech Ignyta (RXDX) for $1.7 billion, the companies said Friday, following Bayer (BAYRY) in buying into a class of experimental cancer drugs that home in on a specific mutation across many types of tumors.

Ignyta investors will get $27 a share in cash, the companies said in a prepared statement. That's 74% higher than Thursday's closing price. Both companies' boards agreed to the deal.

Roche's purchase comes about five weeks after Bayer signed a...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Roche Holding [+]    RHHBY [+]    Ignyta [+]    RXDX [+]    Bayer [+]    BAYRY [+]   

More #news: